Lista de obras -

ANRS HC 02 RIBAVIC: summary and recommandations

artículo científico publicado en 2009

African ethnicity can influence immunological responses to highly active antiretroviral therapy and immunological success at 48 months: a retrospective pilot study

artículo científico publicado en 2013

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort

artículo científico publicado en 2016

Antiretroviral Therapy and Sustained Virological Response to HCV Therapy are Associated with Slower Liver Fibrosis Progression in HIV–HCV-Coinfected Patients: Study from the Anrs Co 13 Hepavih Cohort ⬇️

artículo científico publicado el 10 de octubre de 2012

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.

artículo científico publicado en 2017

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach

artículo científico publicado en 2015

Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response

artículo científico publicado en 2014

Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?

artículo científico publicado en 2017

Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?

artículo científico publicado en 2009

Early neuropsychological adverse events after switching from PI/r to dolutegravir could be related to hyperthyroidism in patients under levothyroxine.

artículo científico publicado en 2016

Editorial: diabetes in HIV-infected patients-do not blame the usual suspect! Authors' reply

scientific article published on 01 August 2018

Effectiveness of an education health programme about Middle East respiratory syndrome coronavirus tested during travel consultations

artículo científico publicado en 2019

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort

artículo científico publicado en 2017

Epidemiology of autoimmune and inflammatory diseases in a French Nationwide HIV cohort.

artículo científico publicado en 2017

Factors Associated with Geophagy and Knowledge About Its Harmful Effects Among Native Sub-Saharan African, Caribbean and French Guiana HIV Patients Living in Northern France.

artículo científico publicado en 2016

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

article

Factors associated with deaths from suicide in a French nationwide HIV-infected cohort

article

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

artículo científico publicado en 2018

Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy

artículo científico publicado en 2009

Hepatitis C: the path towards effective universal therapy

artículo científico publicado en 2016

High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?

artículo científico publicado en 2007

High prevalence of measles seronegativity in adults with HIV infection born in the era of measles vaccination in Northern France.

artículo científico publicado en 2015

Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort

artículo científico publicado en 2013

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen

artículo científico publicado en 2017

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

artículo científico publicado en 2019

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study.

artículo científico publicado en 2016

Macroscopic amoxicillin crystalluria.

artículo científico publicado en 2015

Major Persistent 5' Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues

artículo científico publicado en 2016

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.

artículo científico publicado en 2017

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

artículo científico publicado en 2004

Poor knowledge among French travellers of the risk of acquiring multidrug-resistant bacteria during travel

artículo científico publicado en 2016

Portal hypertension with extensive fibrosis and plasma cell infiltration in multiple myeloma.

artículo científico publicado en 2016

Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy

artículo científico publicado en 2008

Prevalence of geophagy and knowledge about its health effects among native Sub-Saharan Africa, Caribbean and South America healthy adults living in France

scientific article published on 13 December 2018

Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration.

artículo científico publicado en 2017

Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors

artículo científico publicado en 2008

Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient

artículo científico publicado en 2020

Rapidly evolving conjunctivitis due to Pasteurella multocida, occurring after direct inoculation with animal droplets in an immuno-compromised host

artículo científico publicado en 2015

Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response

artículo científico publicado en 2013

Reactivation of hepatitis B virus replication during peginterferon-ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies

artículo científico publicado en 2007

Response to anti-HCV therapy in HIV-HCV-coinfected patients: does the lipid profile really have an effect?

artículo científico publicado en 2010

Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin

artículo científico publicado en 2008

Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients

artículo científico publicado en 2008

Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy

artículo científico publicado en 2005

Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort

article

Severe apoptotic enteropathy caused by methotrexate treatment for rheumatoid arthritis.

artículo científico publicado en 2015

Severe post-artesunate delayed onset anaemia responding to corticotherapy: a case report

artículo científico publicado en 2018

Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment

artículo científico publicado en 2005

Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis

artículo científico publicado en 2013

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice

artículo científico publicado en 2016

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010 ⬇️

artículo científico publicado el 22 de octubre de 2010

Treatment of bone and joint infections caused by Enterobacter cloacae with a fluoroquinolone-cotrimoxazole combination

artículo científico publicado en 2019

Viral triumvirate

artículo científico publicado en 2017

Lista de obras de

ANRS HC 02 RIBAVIC: summary and recommandations

African ethnicity can influence immunological responses to highly active antiretroviral therapy and immunological success at 48 months: a retrospective pilot study

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort

Antiretroviral Therapy and Sustained Virological Response to HCV Therapy are Associated with Slower Liver Fibrosis Progression in HIV–HCV-Coinfected Patients: Study from the Anrs Co 13 Hepavih Cohort ⬇️

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach

Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response

Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?

Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients?

Early neuropsychological adverse events after switching from PI/r to dolutegravir could be related to hyperthyroidism in patients under levothyroxine.

Editorial: diabetes in HIV-infected patients-do not blame the usual suspect! Authors' reply

Effectiveness of an education health programme about Middle East respiratory syndrome coronavirus tested during travel consultations

Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort

Epidemiology of autoimmune and inflammatory diseases in a French Nationwide HIV cohort.

Factors Associated with Geophagy and Knowledge About Its Harmful Effects Among Native Sub-Saharan African, Caribbean and French Guiana HIV Patients Living in Northern France.

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

Factors associated with deaths from suicide in a French nationwide HIV-infected cohort

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

Gamma glutamyl transferase elevation in HIV/Hepatitis C virus-coinfected patients during interferon-ribavirin combination therapy

Hepatitis C: the path towards effective universal therapy

High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?

High prevalence of measles seronegativity in adults with HIV infection born in the era of measles vaccination in Northern France.

Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study.

Macroscopic amoxicillin crystalluria.

Major Persistent 5' Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

Poor knowledge among French travellers of the risk of acquiring multidrug-resistant bacteria during travel

Portal hypertension with extensive fibrosis and plasma cell infiltration in multiple myeloma.

Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy

Prevalence of geophagy and knowledge about its health effects among native Sub-Saharan Africa, Caribbean and South America healthy adults living in France

Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration.

Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors

Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient

Rapidly evolving conjunctivitis due to Pasteurella multocida, occurring after direct inoculation with animal droplets in an immuno-compromised host

Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response

Reactivation of hepatitis B virus replication during peginterferon-ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies

Response to anti-HCV therapy in HIV-HCV-coinfected patients: does the lipid profile really have an effect?

Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin

Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients

Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy

Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort

Severe apoptotic enteropathy caused by methotrexate treatment for rheumatoid arthritis.

Severe post-artesunate delayed onset anaemia responding to corticotherapy: a case report

Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment

Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010 ⬇️

Treatment of bone and joint infections caused by Enterobacter cloacae with a fluoroquinolone-cotrimoxazole combination

Viral triumvirate